---
title: | KRAS
description: KRAS |
---

[![HUB Organoids](https://blog.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "HUB Organoids")](https://huborganoids.nl/)

![merk-m-logo-blue](https://blog.huborganoids.nl/hs-fs/hubfs/merk-m-logo-blue.png?width=728&height=225&name=merk-m-logo-blue.png)

- [services](https://huborganoids.nl/services) 
    - [services overview](https://www.huborganoids.nl/services-overview/)
    - [drug screening](https://www.huborganoids.nl/services/hub-drug-screening/)
    - [model and assay development](https://www.huborganoids.nl/services/)
    - [clinical trials in a dish](https://www.huborganoids.nl/hub-organoid-clinical-trial-in-a-dish/)
- [Technology](https://huborganoids.nl/hub-technology)
- [Company](https://huborganoids.nl/about) 
    - [about us](https://huborganoids.nl/about)
    - [Careers](https://huborganoids.nl/careers)
    - [events](https://www.huborganoids.nl/meet-us/)
    - [latest news](https://www.huborganoids.nl/news-insights-2/)
- [Resources](https://huborganoids.nl/resources/)
- [Blog](https://blog.huborganoids.nl)
- [license program](https://www.huborganoids.nl/licenses/)
- [Contact](https://resources.huborganoids.nl/contact-hub)

[discover organoid services](https://www.huborganoids.nl/services-overview/)

- [services](https://huborganoids.nl/services) 
    - [services overview](https://www.huborganoids.nl/services-overview/)
    - [drug screening](https://www.huborganoids.nl/services/hub-drug-screening/)
    - [model and assay development](https://www.huborganoids.nl/services/)
    - [clinical trials in a dish](https://www.huborganoids.nl/hub-organoid-clinical-trial-in-a-dish/)
- [Technology](https://huborganoids.nl/hub-technology)
- [Company](https://huborganoids.nl/about) 
    - [about us](https://huborganoids.nl/about)
    - [Careers](https://huborganoids.nl/careers)
    - [events](https://www.huborganoids.nl/meet-us/)
    - [latest news](https://www.huborganoids.nl/news-insights-2/)
- [Resources](https://huborganoids.nl/resources/)
- [Blog](https://blog.huborganoids.nl)
- [license program](https://www.huborganoids.nl/licenses/)
- [Contact](https://resources.huborganoids.nl/contact-hub)

# HUB's blog

![The KRAS Conundrum: Challenges and strategies for targeted therapies in cancer](https://blog.huborganoids.nl/hubfs/social-media-KRAS-Conundrum.jpg)

### [The KRAS Conundrum: Challenges and strategies for targeted therapies in cancer](https://blog.huborganoids.nl/the-kras-conundrum-the-challenges-and-strategies-for-targeted-therapies-in-cancer)

Published by Dnyanada Sahasrabudhe on Jul 23, 2024

KRAS is a proto-oncogene that is crucial in regulating cell growth and division. Mutations in the KRAS gene are commonly found in various cancers, including colorectal pancreatic, and lung cancers. These mutations can lead to the constitutive activation of the RAS signaling pathway, promoting ...

[read more](https://blog.huborganoids.nl/the-kras-conundrum-the-challenges-and-strategies-for-targeted-therapies-in-cancer)

![HUB Organoids](https://blog.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "HUB Organoids")

[Privacy Policy](https://huborganoids.nl/privacy-policy)

<https://www.linkedin.com/company/huborganoids/>

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

***FOR RESEARCH USE ONLY.**  Unless otherwise stated in our catalog or other company documentation  
 accompanying the product(s), our products are intended for research use only and are not to be used   
 for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro   
 diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to   
humans or animals.*